Journal of Lipid Research, Vol 38, 1888-1895, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Free fatty acid turnover measured using ultralow doses of [U- 13C]palmitate

Z Guo, S Nielsen, B Burguera and MD Jensen
Endocrine Research Unit, Mayo Clinic, Rochester, MN 55905, USA.

Low intravenous infusion rates of [U-13C]palmitate were used to measure systemic palmitate flux at rest (0.5 nmol . kg-1 . min-1) and during exercise (2 nmol . kg-1 . min-1) in healthy adults. The 13C enrichment of plasma palmitate was determined by gas chromatography/combustion/isotope ratio mass spectrometry (GC/C/IRMS). Palmitate flux was also measured using palmitate radiotracers, which were infused simultaneously to serve as a reference method. Flux values obtained using the two different methods were virtually identical. Overnight postabsorptive palmitate flux was measured on four occasions in three individuals; the flux values were highly reproducible with a coefficient of variation of 11% and 12% for intra-day measurement, and 13% and 8% for inter-day measurement, for [1-(14)C]palmitate and [U- (13)C]palmitate, respectively. During exercise, palmitate turnover measured with [U-(13)C]palmitate and [3H]palmitate were well correlated (r = 0.91). Compared to conventional stable isotope approaches, (e.g., [1-(13)C]palmitate analyzed by GC/MS), [U-(13)C]palmitate reduces the tracer dose by two orders of magnitude when the samples are analyzed with GC/C/IRMS. Uniformly labeled [13C]palmitate is suitable for the measurement of free fatty acid flux in humans.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. H. Nelson, R. Basu, C. M. Johnson, R. A. Rizza, and J. M. Miles Splanchnic Spillover of Extracellular Lipase Generated Fatty Acids in Overweight and Obese Humans Diabetes, December 1, 2007; 56(12): 2878 - 2884. [Abstract] [Full Text] [PDF]

				L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen Energy expenditure, insulin, and VLDL-triglyceride production in humans J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332. [Abstract] [Full Text] [PDF]

				C. Koutsari and M. D. Jensen Thematic review series: Patient-Oriented Research. Free fatty acid metabolism in human obesity J. Lipid Res., August 1, 2006; 47(8): 1643 - 1650. [Abstract] [Full Text] [PDF]

				L. C. Gormsen, M. D. Jensen, and S. Nielsen Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer J. Lipid Res., January 1, 2006; 47(1): 99 - 106. [Abstract] [Full Text] [PDF]

				A. Raman, S. Blanc, A. Adams, and D. A. Schoeller Validation of deuterium-labeled fatty acids for the measurement of dietary fat oxidation during physical activity J. Lipid Res., December 1, 2004; 45(12): 2339 - 2344. [Abstract] [Full Text] [PDF]

				M. Kalivianakis, D. M Minich, R. Havinga, F. Kuipers, F. Stellaard, R. J Vonk, and H. J Verkade Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption Am. J. Clinical Nutrition, July 1, 2000; 72(1): 174 - 180. [Abstract] [Full Text] [PDF]

				M. Kalivianakis, D. M Minich, C. M. Bijleveld, W. M. van Aalderen, F. Stellaard, M. Laseur, R. J Vonk, and H. J Verkade Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids Am. J. Clinical Nutrition, January 1, 1999; 69(1): 127 - 134. [Abstract] [Full Text] [PDF]

				Z. Guo and M. D. Jensen Intramuscular fatty acid metabolism evaluated with stable isotopic tracers J Appl Physiol, May 1, 1998; 84(5): 1674 - 1679. [Abstract] [Full Text] [PDF]